Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Royalty Pharma plc
< Previous
1
2
Next >
Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million
August 25, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Henry Fernandez Steps Down from Royalty Pharma's Board of Directors
August 13, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Reports Second Quarter 2025 Results
August 06, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Declares Third Quarter 2025 Dividend
July 18, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company’s Board of Directors
July 17, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025
July 16, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion
June 24, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
June 04, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Completes the Acquisition of Its External Manager
May 16, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Present at Upcoming Investor Conferences
May 13, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition
May 12, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Reports First Quarter 2025 Results
May 08, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Declares Second Quarter 2025 Dividend
April 21, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025
April 17, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Appoints Vlad Coric, M.D. to the Company’s Board of Directors
April 08, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Announces Upcoming Investor Day
March 27, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Present at TD Cowen’s 45th Annual Health Care Conference
February 27, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Announces R&D Funding Collaboration With Biogen
February 12, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Reports Q4 and Full Year 2024 Results
February 11, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Announces Sale of MorphoSys Development Funding Bonds
January 29, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Announce Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025
January 28, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference
January 10, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Announces Transformative Step in Company’s Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program
January 10, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Announces Dividend Increase
January 09, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Present at Upcoming Investor Conferences
November 27, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Announces Inaugural Prize for Impact in Healthcare
November 14, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million
November 07, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
GERN
RPRX
Royalty Pharma Reports Third Quarter 2024 Results
November 06, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo
November 04, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024
October 16, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.